Life Healthcare Group Holdings Limited
Life Healthcare Group Holdings Limited (LTGHF) Financial Performance & Income Statement Overview
View comprehensive annual and quarterly summaries for Life Healthcare Group Holdings Limited (LTGHF), featuring income statements, balance sheets, and cash flow data.
Life Healthcare Group Holdings Limited (LTGHF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Life Healthcare Group Holdings Limited LTGHF financial performance.
Metric | Q4 2024 | Q2 2024 | Q4 2023 | Q2 2023 |
---|---|---|---|---|
Revenue | $13.93B | $5.93B | $7.35B | $15.29B |
Cost of Revenue | $9.50B | $4.27B | $6.50B | $13.90B |
Gross Profit | $4.43B | $1.66B | $849.00M | $1.39B |
Gross Profit Ratio | $0.32 | $0.28 | $0.12 | $0.09 |
R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
SG&A Expenses | $1.51B | $1.10B | $0.00 | $492.00M |
Operating Expenses | $2.62B | $1.11B | $0.00 | $1.02B |
Total Costs & Expenses | $12.12B | $5.38B | $6.50B | $13.90B |
Interest Income | $0.00 | $158.00M | $99.00M | $60.00M |
Interest Expense | $0.00 | $220.00M | $161.00M | $417.00M |
Depreciation & Amortization | $367.00M | $612.00M | $43812.00 | $1.20B |
EBITDA | $2.26B | $1.87B | $1.15B | $2.54B |
EBITDA Ratio | $0.16 | $0.32 | -$0.03 | $0.17 |
Operating Income | $1.81B | $550.50M | $849.00M | $1.39B |
Operating Income Ratio | $0.13 | $0.09 | $0.12 | $0.09 |
Other Income/Expenses (Net) | -$129.00M | $491.50M | $135.00M | -$473.00M |
Income Before Tax | $1.68B | $1.04B | $984.00M | $918.00M |
Income Before Tax Ratio | $0.12 | $0.18 | $0.13 | $0.06 |
Income Tax Expense | $227.00M | $311.00M | $178.00M | $305.00M |
Net Income | $1.33B | $3.50B | -$283.00M | $547.00M |
Net Income Ratio | $0.10 | $0.59 | -$0.04 | $0.04 |
EPS | $0.89 | $2.43 | -$0.20 | $0.38 |
Diluted EPS | $0.90 | $2.41 | -$0.20 | $0.38 |
Weighted Avg Shares Outstanding | $1.47B | $1.44B | $1.44B | $1.44B |
Weighted Avg Shares Outstanding (Diluted) | $1.46B | $1.45B | $1.44B | $1.45B |
Over the past four quarters, Life Healthcare Group Holdings Limited demonstrated steady revenue growth, increasing from $15.29B in Q2 2023 to $13.93B in Q4 2024. Operating income reached $1.81B in Q4 2024, maintaining a consistent 13% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $2.26B, reflecting operational efficiency. Net income dropped to $1.33B, with EPS at $0.89. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan